PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Confident in Preclinical Work on Its Novel Ketamine Formulation

Nov 3, 2022

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company, is focused on fusing traditional therapeutics with psychedelic research to provide novel treatments for numerous indications, including post-traumatic stress disorder (“PTSD”), fibromyalgia, Alzheimer’s disease, and other rare neurological disorders. “Silo Pharma is currently developing ketamine treatments for fibromyalgia – a chronic disease that causes pain throughout the body. With no cure available, fibromyalgia can be a debilitating condition that extends beyond the pain to cause extreme fatigue, anxiety and memory issues. Silo’s novel ketamine formulation, designated as SP-26, is currently undergoing safety evaluation to treat fibromyalgia,” reads a recent article. “We are working closely with our joint venture partner Zylö Therapeutics in developing a topical sustained released ketamine utilizing Z-pod(TM) technology. Preclinical studies have already shown that our joint-developed delivery method and formulation can hold and distribute ketamine in a time-released manner. SP-26 reported positive results in reducing neuropathic nerve pain. This safety evaluation study will uncover maximum tolerated dosing data that will inform our future trials… We are confident that our highly constructive preclinical work on SP-26 will offer strong support for our pre-IND package as we seek to advance our time-released ketamine delivery system into the clinic,” Silo Pharma CEO Eric Weisblum is quoted as saying.

To view the full article, visit https://ibn.fm/GfaAa

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Parkinson’s and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which the company believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.

More News

Salon owners urge Budget VAT cut as staffing pressures grow
Oct 26, 2026
Salon owners urge Budget VAT cut as staffing pressures grow

Marcus Perkins, who owns a hair and beauty salon in Brierley Hill, says he is scared for the future.

Healey to shield low-income pensioners from income tax in the Budget
Oct 26, 2026
Healey to shield low-income pensioners from income tax in the Budget

Changes are needed to prevent the full, flat-rate state pension becoming liable for income tax after it rises in April.

Why Some People Are Paying to Make Friends
Oct 26, 2026
Why Some People Are Paying to Make Friends

Apps that match personalities — for a price — have surged in popularity amid a loneliness epidemic.

What is the Budget and what could be in it?
Oct 26, 2026
What is the Budget and what could be in it?

Chancellor John Healey will set out his plans for UK taxes on 28 October.

Healey's Budget needs to sustain the stronger economy through gathering clouds
Oct 26, 2026
Healey's Budget needs to sustain the stronger economy through gathering clouds

The economic is positive now but come January things could become trickier for the Labour government

Big, noisy and coming to a town near you - why the data centre backlash is growing
Oct 25, 2026
Big, noisy and coming to a town near you - why the data centre backlash is growing

Data centres are the lifeblood of our digital world, but there are growing concerns about their environmental impact. The BBC explores their rise in charts.

Attention, Passengers: High Airfares May Be Here to Stay
Oct 25, 2026
Attention, Passengers: High Airfares May Be Here to Stay

Ticket prices jumped after fuel costs spiked because of the war with Iran, but airlines say even an end to the conflict will not bring fares back down quickly.

A Fight Over Felon Voting Prompts a Free Speech Debate
Oct 25, 2026
A Fight Over Felon Voting Prompts a Free Speech Debate

A Minnesota group worried that its opposition could expose it to prosecution under the state’s deceptive-practices law. Its lawsuit could have wide implications for limiting speech around elections.

Noah Adams, Longtime Host of ‘All Things Considered,’ Has Died at 84
Oct 25, 2026
Noah Adams, Longtime Host of ‘All Things Considered,’ Has Died at 84

A postman’s son from Kentucky, he worked hard to lose his accent but never forgot his Appalachian roots. “The best stories come from west of the Potomac,” he said.

Business Daily
Oct 25, 2026
Business Daily

A Chinese export surge has implications far beyond its borders

How to Straddle the MAGA Divide
Oct 25, 2026
How to Straddle the MAGA Divide

Beth Wilkinson is a Washington lawyer who has thrived representing the Trump administration’s enemies and allies alike. Does she represent a vanishing type?

Audi to Build Factory in Georgia, Trump Says
Oct 25, 2026
Audi to Build Factory in Georgia, Trump Says

The Volkswagen division, which imports all its cars from Europe or Mexico, has been hit hard by U.S. tariffs.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Manage The Numbers

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Newsletter